Related Experiment Video
Updated: Jun 24, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Bronchiolitis: from empiricism to scientific evidence
S Carraro1, S Zanconato, E Baraldi
1Unit of Pneumology and Allergology, Pediatric Department, University of Padua, Padua, Italy.
Insights
Bronchiolitis, a common infant respiratory infection caused by RSV, requires updated management strategies. This review synthesizes new international guidelines on diagnosis, treatment, and prevention for infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is the most frequent viral infection of the lower respiratory tract in infants, peaking between 3-9 months.
- Inflammatory obstruction of small airways characterizes the clinical presentation.
- Respiratory syncytial virus (RSV) is the primary etiological agent, implicated in over 50% of cases.
Purpose of the Study:
- To provide an updated overview of pediatric bronchiolitis management.
- To discuss key aspects of diagnosis, treatment, and prevention.
- To align clinical practice with recent international guidelines.
Main Methods:
- Review of the first international guidelines on bronchiolitis management.
- Synthesis of recommendations from the American Academy of Pediatrics (AAP) and the Scottish Intercollegiate Guidelines Network (SIGN).
- Discussion of salient points for clinical application.
Main Results:
- New international guidelines offer updated approaches to bronchiolitis care.
- Emphasis on evidence-based strategies for diagnosis, treatment, and prevention.
- Harmonization of recommendations from major pediatric and respiratory societies.
Conclusions:
- Updated management strategies for infant bronchiolitis are crucial.
- Adherence to new international guidelines can improve patient outcomes.
- Further research may refine evidence-based care for this common childhood illness.
Abstract:
Bronchiolitis is the most common viral infection of the lower respiratory tract in infants in their first year of life, with an incidence peak between 3 and 9 months of age. The clinical profile of bronchiolitis results from the inflammatory obstruction of the small airways. The etiological agent involved is respiratory syncytial virus (RSV) in more than 50% of cases. The first international guidelines on the management of children with bronchiolitis have recently been published. The first was produced by a special subcommittee created by the American Academy of Pediatrics (AAP) with the support of a few important international associations that deal with respiratory diseases including the American Thoracic Society and the European Respiratory Society; the second was drawn up by the Scottish Intercollegiate Guidelines Network (SIGN). This review sets out to update the management of children with bronchiolitis by discussing the salient points relating to diagnosis, treatment and prevention on the basis of the recommendations in these documents.
Related Concept Videos
Asthma I: Introduction
Criteria for Causality: Bradford Hill Criteria - II
Respiratory Syncytial Virus Disease
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Microbiota of the Respiratory Tract
Pulmonary Cycle: Exhalation
